desipramine and 5,7,3'-trihydroxy-3,4'-dimethoxyflavone

desipramine has been researched along with 5,7,3'-trihydroxy-3,4'-dimethoxyflavone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Estévez, F; Quintana, J; Torres, F	1

Other Studies

1 other study(ies) available for desipramine and 5,7,3'-trihydroxy-3,4'-dimethoxyflavone

Article	Year
5,7,3'-Trihydroxy-3,4'-dimethoxyflavone inhibits the tubulin polymerization and activates the sphingomyelin pathway. Molecular carcinogenesis, 2011, Volume: 50, Issue:2 Topics: Animals; Antineoplastic Agents; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle; Cell Death; Cell Line, Tumor; Cyclin B1; Desipramine; Female; Flavones; HL-60 Cells; Humans; Leukemia; Mice; Mice, Nude; Phosphorylation; Polymerization; Sphingomyelin Phosphodiesterase; Sphingomyelins; Tubulin; Tubulin Modulators; U937 Cells; Xenograft Model Antitumor Assays	2011

Article

Year

5,7,3'-Trihydroxy-3,4'-dimethoxyflavone inhibits the tubulin polymerization and activates the sphingomyelin pathway.

Molecular carcinogenesis, 2011, Volume: 50, Issue:2

Topics: Animals; Antineoplastic Agents; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle; Cell Death; Cell Line, Tumor; Cyclin B1; Desipramine; Female; Flavones; HL-60 Cells; Humans; Leukemia; Mice; Mice, Nude; Phosphorylation; Polymerization; Sphingomyelin Phosphodiesterase; Sphingomyelins; Tubulin; Tubulin Modulators; U937 Cells; Xenograft Model Antitumor Assays

2011